Journal ArticleJournal of Experimental & Clinical Cancer Research · October 19, 2023
AbstractBackgroundEpithelial ovarian cancer (EOC) is a global health burden, with the poorest five-year survival rate of the gynecological malignancies du ...
Full textCite
Journal ArticleProceedings of the National Academy of Sciences of the United States of America · April 2023
The hypoxia-inducible factor 1-α (HIF-1α) enables cells to adapt and respond to hypoxia (Hx), and the activity of this transcription factor is regulated by several oncogenic signals and cellular stressors. While the pathways controlling normoxic degradatio ...
Full textOpen AccessCite
Journal ArticleFrontiers in Oncology · March 17, 2022
Epithelial ovarian cancer (EOC) is a global health burden and remains the fifth leading cause of cancer related death in women worldwide with the poorest five-year survival rate of the gynecological malignancies. EOC recurrence is considered to be ...
Full textOpen AccessCite
Journal ArticleCancers · June 21, 2020
Disease recurrence is the major cause of morbidity and mortality of ovarian cancer (OC). In terms of maintenance therapies after platinum-based chemotherapy, PARP inhibitors significantly improve the overall survival of patients with BRCA mutations ...
Full textOpen AccessCite